Completed (3)

phase 1 (2)

phase 2 (1)

National Cancer Institute (NCI) (2)

Children's Oncology Group (1)

National Cancer Institute (NCI) (1)

pharmacological study (2)

akt inhibitor mk2206 (1)

diagnostic laboratory biomarker analysis (1)

etanercept (1)

laboratory biomarker analysis (1)

methylprednisolone (1)

sunitinib malate (1)

drug (3)

other (2)

biological (1)

NIH (2)

Other (1)

Interventional (3)

accelerated phase chronic myelogenous leukemia

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS